{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T23:03:37Z","timestamp":1779663817040,"version":"3.53.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45771-z","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T17:27:31Z","timestamp":1775237251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis, SAR, and multi-target evaluation of isonicotinoyl hydrazones as potent MPO\/AChE inhibitors and metal chelators for Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Zeyang","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"45771_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"45771_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuroscience.2020.11.015","volume":"457","author":"J Avila","year":"2021","unstructured":"Avila, J. & Perry, G. A multilevel view of the development of Alzheimer\u2019s disease. Neuroscience 457, 283\u2013293 (2021).","journal-title":"Neuroscience"},{"key":"45771_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-160882","volume":"57","author":"FT Hane","year":"2017","unstructured":"Hane, F. T., Lee, B. Y. & Leonenko, Z. Recent progress in Alzheimer\u2019s disease research, Part 1: pathology. J. Alzheimers Dis. 57, 1\u201328 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"45771_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-024-00531-z","volume":"10","author":"DS Knopman","year":"2024","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Primers 10, 42 (2024).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"45771_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai, R., Guo, J., Ye, X. Y., Xie, Y. & Xie, T. Oxidative stress: the core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res. Rev. 77, 101619 (2022).","journal-title":"Ageing Res. Rev."},{"key":"45771_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1441147","volume":"15","author":"J Sankar","year":"2024","unstructured":"Sankar, J., Chauhan, A., Singh, R. & Mahajan, D. Isoniazid: historical development, metabolism associated toxicity and a perspective on its pharmacological improvement. Front. Pharmacol. 15, 1441147 (2024).","journal-title":"Front. Pharmacol."},{"key":"45771_CR7","volume":"1312","author":"CC Frias","year":"2024","unstructured":"Frias, C. C. et al. Acylhydrazones derived from isonicotinic acid: synthesis, characterization, and evaluation against Alzheimer\u2019s disease biomarkers. J. Mol. Struct. 1312, 138456 (2024).","journal-title":"J. Mol. Struct."},{"key":"45771_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115470","volume":"28","author":"DC Santos","year":"2020","unstructured":"Santos, D. C. et al. Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer\u2019s disease: radical scavenging, myeloperoxidase\/acetylcholinesterase inhibition and biometal chelation. Bioorg. Med. Chem. 28, 115470 (2020).","journal-title":"Bioorg. Med. Chem."},{"key":"45771_CR9","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"A Singh","year":"2019","unstructured":"Singh, A., Kukreti, R., Saso, L. & Kukreti, S. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules 24, 1583 (2019).","journal-title":"Molecules"},{"key":"45771_CR10","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1021\/acs.jmedchem.3c00770","volume":"66","author":"A Cipriano","year":"2023","unstructured":"Cipriano, A. et al. NADPH oxidases: from molecular mechanisms to current inhibitors in anticancer therapy. J. Med. Chem. 66, 7926\u20137955 (2023).","journal-title":"J. Med. Chem."},{"key":"45771_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","volume":"5","author":"E Birben","year":"2012","unstructured":"Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S. & Kalayci, O. Oxidative stress and antioxidant defense. World Allergy Organ. J. 5, 9\u201319 (2012).","journal-title":"World Allergy Organ. J."},{"key":"45771_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2025.2456282","volume":"40","author":"AM Rivera Antonio","year":"2025","unstructured":"Rivera Antonio, A. M., Padilla Mart\u00ednez, I. I., Torres-Ramos, M. A. & Rosales-Hern\u00e1ndez, M. C. Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer\u2019s disease. J. Enzyme Inhib. Med. Chem. 40, 2456282 (2025).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"45771_CR13","doi-asserted-by":"publisher","first-page":"2525967","DOI":"10.1155\/2017\/2525967","volume":"2017","author":"Z Liu","year":"2017","unstructured":"Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P. & Zuo, L. Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid. Med. Cell. Longev. 2017, 2525967 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"45771_CR14","doi-asserted-by":"publisher","first-page":"2431832","DOI":"10.1080\/14756366.2024.2431832","volume":"39","author":"M Bartoli\u0107","year":"2024","unstructured":"Bartoli\u0107, M., Mato\u0161evi\u0107, A., Marakovi\u0107, N. & Ga\u0161o-Soka\u010d, D. Evaluation of hydrazone and N-acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer\u2019s disease. J. Enzyme Inhib. Med. Chem. 39, 2431832 (2024).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"45771_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2270781","volume":"38","author":"D Zou","year":"2023","unstructured":"Zou, D. et al. Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer\u2019s disease. J. Enzyme Inhib. Med. Chem. 38, 2270781 (2023).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"45771_CR16","first-page":"1","volume":"72","author":"M Kondeva-Burdina","year":"2025","unstructured":"Kondeva-Burdina, M., Krastev, K., Pencheva, T. & Angelova, V. T. Indole-based hydrazide-hydrazone and sulfonylhydrazone derivatives as MAO-B inhibitors with multitarget potential for neurodegenerative diseases. Pharmacia 72, 1\u201313 (2025).","journal-title":"Pharmacia"},{"key":"45771_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejmech.2012.01.030","volume":"49","author":"SM Siddiqui","year":"2012","unstructured":"Siddiqui, S. M., Salahuddin, A. & Azam, A. Synthesis, characterization and antiamoebic activity of some hydrazone and azole derivatives bearing pyridyl moiety as a promising heterocyclic scaffold. Eur. J. Med. Chem. 49, 411\u2013416 (2012).","journal-title":"Eur. J. Med. Chem."},{"key":"45771_CR18","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00044-011-9662-9","volume":"21","author":"V Judge","year":"2012","unstructured":"Judge, V. et al. Isonicotinic acid hydrazide derivatives: synthesis, antimicrobial activity, and QSAR studies. Med. Chem. Res. 21, 1451\u20131470 (2012).","journal-title":"Med. Chem. Res."},{"key":"45771_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/s-0033-1363976","volume":"64","author":"SG Alegaon","year":"2014","unstructured":"Alegaon, S. G., Alagawadi, K. R. & Dadwe, D. H. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives. Drug Res. (Stuttg.) 64, 553\u2013558 (2014).","journal-title":"Drug Res. (Stuttg.)"},{"key":"45771_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1152\/physrev.00030.2022","volume":"104","author":"M Perluigi","year":"2024","unstructured":"Perluigi, M., Di Domenico, F. & Butterfield, D. A. Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease. Physiol. Rev. 104, 233\u2013270 (2024).","journal-title":"Physiol. Rev."},{"key":"45771_CR21","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1016\/j.ejmech.2010.03.031","volume":"45","author":"N Belkheiri","year":"2010","unstructured":"Belkheiri, N. et al. Synthesis and antioxidant activity evaluation of a syringic hydrazones family. Eur. J. Med. Chem. 45, 3019\u20133026 (2010).","journal-title":"Eur. J. Med. Chem."},{"key":"45771_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00044","volume":"14","author":"NE Uzor","year":"2020","unstructured":"Uzor, N. E., McCullough, L. D. & Tsvetkov, A. S. Peroxisomal dysfunction in neurological diseases and brain aging. Front. Cell. Neurosci. 14, 44 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"45771_CR23","volume":"25","author":"Y Yu","year":"2024","unstructured":"Yu, Y., Yu, S., Battaglia, G. & Tian, X. Amyloid-\u03b2 in Alzheimer\u2019s disease: structure, toxicity, distribution, treatment, and prospects. Int. J. Mol. Sci. 25, 10705 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"45771_CR24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid2007.140087","volume":"20","author":"D Bitar","year":"2014","unstructured":"Bitar, D. et al. Population-based analysis of invasive fungal infections, France. Emerg. Infect. Dis. 20, 1149\u20131155 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"45771_CR25","first-page":"345","volume":"212","author":"DI Pattison","year":"2024","unstructured":"Pattison, D. I., Hawkins, C. L. & Davies, M. J. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Free Radic. Biol. Med. 212, 345\u2013358 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"45771_CR26","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/molecules27041326","volume":"27","author":"S Baliyan","year":"2022","unstructured":"Baliyan, S. et al. Determination of antioxidants by DPPH radical scavenging activity and quantitative phytochemical analysis of Ficus religiosa. Molecules 27, 1326 (2022).","journal-title":"Molecules"},{"key":"45771_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102532","volume":"58","author":"W Chen","year":"2022","unstructured":"Chen, W. et al. Therapeutic inhibition of MPO stabilizes pre-existing high risk atherosclerotic plaque. Redox Biol. 58, 102532 (2022).","journal-title":"Redox Biol."},{"key":"45771_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031232","volume":"28","author":"RG Cabral","year":"2023","unstructured":"Cabral, R. G., Viegas, G., Pacheco, R., Sousa, A. C. & Robalo, M. P. Sustainable synthesis, antiproliferative and acetylcholinesterase inhibition of 1,4- and 1,2-naphthoquinone derivatives. Molecules 28, 1232 (2023).","journal-title":"Molecules"},{"key":"45771_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.biophys.37.032807.125811","volume":"37","author":"T Dudev","year":"2008","unstructured":"Dudev, T. & Lim, C. Metal binding affinity and selectivity in metalloproteins: insights from computational studies. Annu. Rev. Biophys. 37, 97\u2013116 (2008).","journal-title":"Annu. Rev. Biophys."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45771-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45771-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45771-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T22:32:47Z","timestamp":1779661967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45771-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45771"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45771-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve any human participants or animals. Therefore, ethical approval was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"16041"}}